These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 38720322)
1. Construction of lymph nodes-targeting tumor vaccines by using the principle of DNA base complementary pairing to enhance anti-tumor cellular immune response. Zha Y; Fu L; Liu Z; Lin J; Huang L J Nanobiotechnology; 2024 May; 22(1):230. PubMed ID: 38720322 [TBL] [Abstract][Full Text] [Related]
2. MnO Song T; Liao Y; Zuo Q; Liu N; Liu Z J Mater Chem B; 2022 May; 10(18):3474-3490. PubMed ID: 35403638 [TBL] [Abstract][Full Text] [Related]
3. Uplifting Antitumor Immunotherapy with Lymph-Node-Targeted and Ratio-Controlled Codelivery of Tumor Cell Lysate and Adjuvant. Cui G; Sun Y; Qu L; Shen C; Sun Y; Meng F; Zheng Y; Zhong Z Adv Healthc Mater; 2024 Jul; 13(17):e2303690. PubMed ID: 38458152 [TBL] [Abstract][Full Text] [Related]
4. Enhancing efficacy of anticancer vaccines by targeted delivery to tumor-draining lymph nodes. Jeanbart L; Ballester M; de Titta A; Corthésy P; Romero P; Hubbell JA; Swartz MA Cancer Immunol Res; 2014 May; 2(5):436-47. PubMed ID: 24795356 [TBL] [Abstract][Full Text] [Related]
5. Effects of gold nanoparticle-based vaccine size on lymph node delivery and cytotoxic T-lymphocyte responses. Kang S; Ahn S; Lee J; Kim JY; Choi M; Gujrati V; Kim H; Kim J; Shin EC; Jon S J Control Release; 2017 Jun; 256():56-67. PubMed ID: 28428066 [TBL] [Abstract][Full Text] [Related]
6. Enhanced antitumor immunity by targeting dendritic cells with tumor cell lysate-loaded chitosan nanoparticles vaccine. Shi GN; Zhang CN; Xu R; Niu JF; Song HJ; Zhang XY; Wang WW; Wang YM; Li C; Wei XQ; Kong DL Biomaterials; 2017 Jan; 113():191-202. PubMed ID: 27816821 [TBL] [Abstract][Full Text] [Related]
7. Microdosed Lipid-Coated (67)Ga-Magnetite Enhances Antigen-Specific Immunity by Image Tracked Delivery of Antigen and CpG to Lymph Nodes. Ruiz-de-Angulo A; Zabaleta A; Gómez-Vallejo V; Llop J; Mareque-Rivas JC ACS Nano; 2016 Jan; 10(1):1602-18. PubMed ID: 26678549 [TBL] [Abstract][Full Text] [Related]
8. Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells. Le Moignic A; Malard V; Benvegnu T; Lemiègre L; Berchel M; Jaffrès PA; Baillou C; Delost M; Macedo R; Rochefort J; Lescaille G; Pichon C; Lemoine FM; Midoux P; Mateo V J Control Release; 2018 May; 278():110-121. PubMed ID: 29630987 [TBL] [Abstract][Full Text] [Related]
9. Intratumoral injection of alpha-gal glycolipids induces xenograft-like destruction and conversion of lesions into endogenous vaccines. Galili U; Wigglesworth K; Abdel-Motal UM J Immunol; 2007 Apr; 178(7):4676-87. PubMed ID: 17372027 [TBL] [Abstract][Full Text] [Related]
10. Synthetic vaccine nanoparticles target to lymph node triggering enhanced innate and adaptive antitumor immunity. Kim SY; Noh YW; Kang TH; Kim JE; Kim S; Um SH; Oh DB; Park YM; Lim YT Biomaterials; 2017 Jun; 130():56-66. PubMed ID: 28364631 [TBL] [Abstract][Full Text] [Related]
11. In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity. Villegas-Mendez A; Garin MI; Pineda-Molina E; Veratti E; Bueren JA; Fender P; Lenormand JL Mol Ther; 2010 May; 18(5):1046-53. PubMed ID: 20179681 [TBL] [Abstract][Full Text] [Related]
12. Cascade Cytosol Delivery of Dual-Sensitive Micelle-Tailored Vaccine for Enhancing Cancer Immunotherapy. Jiang D; Mu W; Pang X; Liu Y; Zhang N; Song Y; Garg S ACS Appl Mater Interfaces; 2018 Nov; 10(44):37797-37811. PubMed ID: 30360105 [TBL] [Abstract][Full Text] [Related]
13. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells. Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613 [TBL] [Abstract][Full Text] [Related]
14. Immune Adjuvant Targeting Micelles Allow Efficient Dendritic Cell Migration to Lymph Nodes for Enhanced Cellular Immunity. Yang X; Lian K; Meng T; Liu X; Miao J; Tan Y; Yuan H; Hu F ACS Appl Mater Interfaces; 2018 Oct; 10(39):33532-33544. PubMed ID: 30192498 [TBL] [Abstract][Full Text] [Related]
15. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma. Goforth R; Salem AK; Zhu X; Miles S; Zhang XQ; Lee JH; Sandler AD Cancer Immunol Immunother; 2009 Apr; 58(4):517-30. PubMed ID: 18719913 [TBL] [Abstract][Full Text] [Related]
16. Manganese-mineralized cancer cells as immunogenic cancer vaccines for tumor immunotherapy. Liu Z; Lin J; Li B; Zhou Y; Li C; Cui Y; Tian F; Tang R; Wang X J Mater Chem B; 2023 Nov; 11(45):10923-10928. PubMed ID: 37934507 [TBL] [Abstract][Full Text] [Related]
17. High Cellular Internalization of Virus-Like Mesoporous Silica Nanoparticles Enhances Adaptive Antigen-Specific Immune Responses against Cancer. Phan NM; Nguyen TL; Choi Y; Mo XW; Trinh TA; Yi GR; Kim J ACS Appl Mater Interfaces; 2024 Sep; 16(35):45917-45928. PubMed ID: 39178210 [TBL] [Abstract][Full Text] [Related]
18. A Magnetically Driven Biodegradable Microsphere with Mass Production Capability for Subunit Vaccine Delivery and Enhanced Immunotherapy. Zhang Q; Qu Y; Zhao H; Chen S; Liu Z; Li J; Li Y; Li J; Sun D ACS Appl Mater Interfaces; 2024 Sep; 16(38):50344-50359. PubMed ID: 39265074 [TBL] [Abstract][Full Text] [Related]
19. Targeted antigen delivery to dendritic cell via functionalized alginate nanoparticles for cancer immunotherapy. Zhang C; Shi G; Zhang J; Song H; Niu J; Shi S; Huang P; Wang Y; Wang W; Li C; Kong D J Control Release; 2017 Jun; 256():170-181. PubMed ID: 28414151 [TBL] [Abstract][Full Text] [Related]
20. Immunization with tumor neoantigens displayed on T7 phage nanoparticles elicits plasma antibody and vaccine-draining lymph node B cell responses. Shukla GS; Sun YJ; Pero SC; Sholler GS; Krag DN J Immunol Methods; 2018 Sep; 460():51-62. PubMed ID: 29906453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]